CD58 and neoplasm: Subsequently, Kaplan–Meier analysis showed the OS (p = 0.0003, Fig. 2c) and tumor-free survival (p = 0.0023, Fig. 2d) of patients with high CD58 expression were significantly inferior to those with low CD58 expression.